Innovent Biologics Receives Breakthrough Therapy Designation for IBI343 in Advanced Gastric Cancer Treatment

Innovent Biologics a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncol...

May 07, 2024 | Tuesday | News
Sciwind Biosciences and HK inno.N Partner to Advance Ecnoglutide for Diabetes and Obesity in South Korea

Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...

May 07, 2024 | Tuesday | News
AbbVie Pledges €150 Million for State-of-the-Art R&D Facility in Germany, Fostering Innovation

New state-of-the-art research and development (R&D) facility at Ludwigshafen to expand discovery and development of new medicines across core therape...

May 01, 2024 | Wednesday | News
INTREPID Alliance Identifies Most Promising Antiviral Compounds in Global Pipeline Aligned with Pandemic Preparedness Recommendations

Detailed scientific analysis of antiviral pipeline identifies most promising clinical compounds aligned with 100 Days Mission global preparedness recommend...

April 29, 2024 | Monday | News
Avistone Biotechnology's Vebreltinib Granted Historic Approval for Glioma Treatment by Chinese NMPA, Paving the Way for Targeted Therapy Breakthroughs in 2024

Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision...

April 26, 2024 | Friday | News
Hyundai Bioscience Announces Clinical Development Plan for Oral Niclosamide Metabolic Anticancer Drug Targeting p53 Gene Mutations

Hyundai Bioscience announced its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cance...

April 25, 2024 | Thursday | News
Shanghai Junshi Biosciences' Toripalimab NDA Accepted by Hong Kong DO for Groundbreaking Nasopharyngeal Carcinoma Treatment

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel...

April 25, 2024 | Thursday | News
Sanofi's Breakthrough BTK Inhibitor Shows Promise for Patients with Persistent and Chronic ITP, Regulatory Submissions Expected Soon

Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia Pivotal data from the first phase 3 study of a BTKi in immune thrombo...

April 23, 2024 | Tuesday | News
INTERPHEX 2024 Sheds Light on Cutting-Edge Solutions: Leveraging AI for Fraud Detection in Pharma

Conference Session Recap: Leveraging AI for Fraud Detection in Pharma - Insights from INTERPHEX 2024  Attendees at INTERPHEX 2024 were treated to a t...

April 16, 2024 | Tuesday | News
Cytiva to Showcase Cutting-Edge Bioprocessing Innovations at INTERPHEX 2024

Cytiva, a global leader in life sciences solutions, proudly announces its participation at INTERPHEX 2024, where it will unveil its latest advancements in ...

April 16, 2024 | Tuesday | News
SaniSure accelerates drug speed to market with Fill4Sure launch

Fill4Sure™ provides an innovative solution to the critical challenges drug manufacturers experience throughout the fill-finish process, such as high ...

April 12, 2024 | Friday | News
ACROBiosystems Launches Organoid Toolbox to Advance Organoid Research

Observation: ACROBiosystems' relentless commitment to innovation and strategic partnerships underscores its pivotal role in advancing organoid research and...

April 10, 2024 | Wednesday | News
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Collaboration to advance TheWell Bioscience animal-free hydrogel solutions for 3D cell models Solutions address shift from animal-based to more human-re...

April 09, 2024 | Tuesday | News
Shorla Oncology's Palatable Oral Liquid for Leukemia Enters FDA Review Process

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced  that the U.S. Food and Drug Administration (FDA) h...

April 08, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close